| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ferrari NV (NYSE:RACE) has unveiled E-Cells Lab, a research center for electrochemistry within the University of Bologna.
The laboratory, set up under the university’s scientific direction, aims to build knowledge of the materials, and the chemical and physical properties, of lithium cells.
The applications developed in E-Cells Lab will be shared with the electronics company NXP Semiconductors N.V. (NASDAQ:NXPI), technology partner and supporter of the project.
The laboratory consists of two areas: the first is dedicated to preparing electrochemical materials, and the second to analyzing, testing, and determining the characteristics of the materials.
The research will also focus on solid states, fast charging, thermal charging, cell safety and performance.
The findings will help Ferrari in optimizing the performance of the batteries that will be assembled in the Maranello plants.
“E-Cells Lab represents an exciting beginning and demonstrates our commitment to education and research. The project also reflects the importance that the confluence between the academic and business worlds has always had for us,” said CEO Benedetto Vigna.
Price Action: RACE shares are trading higher by 0.66% at $421.62 in premarket on the last check Monday.
Photo via Shutterstock
